NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

But it’s more or less a side show anyway, since by the time it takes this case to progress to a point where there might be a settlement, all the milestones (i.e., RA submissions, approvals, uplisting, partnerships, etc.,) that impact the business will be already determined, one way or another.

Not true! Even if NWBO were to have become a major biopharma, this spoofing case (and other manipulation cases) will remain an important and significant case in its own right, and definitely worth pursuing to the end. The spoofing case is far more than just a stepping stone to a settlement and some much welcome cash for NWBO to pursue its goals.